Question

Use Bayes theorem to answer the following question. A screening test for Hepatitis B in blood...

Use Bayes theorem to answer the following question. A screening test for Hepatitis B in blood donors has been determined to have a sensitivity of 0.97 and a specificity of 0.96. If the prevalence (what is exist) of hepatitis B in the Canadian population is 10 out of 1000 people what is the predictive value of this test for a positive result?

Homework Answers

Answer #1

Please let me know if you have any doubts. Happy to help.Please thumbs up if you like the solution. Thanks

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
A new screening test for COVID-19 was administered to 1,000 adults at a large medical center...
A new screening test for COVID-19 was administered to 1,000 adults at a large medical center in Texas. The results showed that 152 out of 160 diagnosed cases of COVID-19 were correctly identified by the screening test. Of the 840 individuals without COVID-19, the screening test correctly identified 714. Based upon this information: 1. Calculate the test's sensitivity, specificity, and the positive and negative predictive values. 2. Calculate the prevalence rate of COVID-19 in this population and the accuracy of...
You will be assessing the appropriateness of a new screening test for Disease X. Assume a...
You will be assessing the appropriateness of a new screening test for Disease X. Assume a population of 1000 people of whom 100 have Disease X and 900 do not have Disease X to answer questions a through i using the following 2x2 table: Disease No Disease Positive screen 80 100 Negative screen 20 800 1.      Calculate the sensitivity. 2.      Interpret your sensitivity calculation and the implications for potential use of this screening test. 3.       Calculate the specificity. 4.      Interpret your specificity calculation and...
Suppose that a screening test for breast cancer has 95% sensitivity and 90% specificity. Assume 1%...
Suppose that a screening test for breast cancer has 95% sensitivity and 90% specificity. Assume 1% of the population being screened truly has breast cancer. a. If you really do have breast cancer, what is the probability that the test says you do? b. If you really do not have breast cancer, what is the probability that the test says you do? c. The screening test is applied to a total of 15 people; 5 who really do have cancer...
Table 1 below shows results obtained in a new screening test for diabetes. 10,000 people were...
Table 1 below shows results obtained in a new screening test for diabetes. 10,000 people were screened. The cut-off level employed was 180mg of blood glucose per 100 ml. Everyone scoring above this level was classified as positive for diabetes. Everyone scoring below this level was classified as negative for diabetes. These results were compared to a “gold standard” test for diabetes that is considered to be completely valid. Compute and interpret the sensitivity, specificity, positive predictive value (PPV) and...
Diabetes Screening Shown below are the real-life diagnostic characteristics of a particular diabetes-screening test – a...
Diabetes Screening Shown below are the real-life diagnostic characteristics of a particular diabetes-screening test – a fasting venous glucose measurement – from a hypothetical cross-sectional study population. Calculate the sensitivity, specificity and positive predictive value (PPV) of this screening test and estimate the prevalence of diabetes in the study population. Table: Results of fasting venous glucose screening for diabetes. Diabetes Screening Test Actual diabetes status Total Present Absent Positive (+) True + 67 False + 38 Total + 105 Negative...
Question 1. The main purpose of screening is to identify symptomatic disease using tests, exams, or...
Question 1. The main purpose of screening is to identify symptomatic disease using tests, exams, or other procedures. True False Question 2. The detectable pre-clinical phase of a disease starts when the disease can be identified by a screening test and ends when the disease produces symptoms. True False Question 3 .Diseases that are appropriate for screening… a. Have serious consequences b. Have a treatment that is more effective at an earlier stage c. Have a detectable preclinical phase that...
You work at a screening center that can process 1,000 people per week. Assume you are...
You work at a screening center that can process 1,000 people per week. Assume you are attempting the early detection of a disease with a prevalence of 2% and that your test has a sensitivity of 95% and a specificity of 90%. Key facts: - 1,000 tests per week - Early detection - 2% prevalence - 95% sensitivity - 90% specificity 13. Complete the following 2 x 2 table (4 points): Gold Standard Present Absent Total Test result Positive a...
Using the following 2x2 table calculate the prevalence of the disease , sensitivity of the test,...
Using the following 2x2 table calculate the prevalence of the disease , sensitivity of the test, specificity of the test , predictive value of a positive test Disease Present Absent Test Result Positive 34 20 Negative 116 9830 Prevalence Sensitivity Specificity Predictivity value of a positive test A. 99.7% B. 31% C. 63% D. 1.5% E. 59% F. 22.6% G. 25%
Assume that out of a population of 1,000, the probability of having a certain disease is...
Assume that out of a population of 1,000, the probability of having a certain disease is 1%. The screening for the disease has a sensitivity of 80% and a specificity of 80%. Using Bayes' theorem, 206 people will test positive for the disease, and, of this number, actually do not have the disease. A. 8 B. 198 C. 10 D. 2
what is the correct answer.. 1- In raising the cutoff point for a screening test, which...
what is the correct answer.. 1- In raising the cutoff point for a screening test, which of the following is the likely result? A An increase in sensitivity B An increase in specificity C An increase in false positives D An increase in prevalence E An increase in lead time bias 2- If the screening test does not delay the time of death from a condition but makes survival appear longer because of earlier detection of disease, there is evidence...